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To elucidate the participation of sphingosine and 
ceramide in the biologic action of cytokines on epi-
dermal keratinocytes, we studied whether inhibitors 
of sphingolipid synthesis modulate interferon (IFN)-
y-induced intercellular adhesion molecule (ICAM)-l 
and human leukocyte antigen (HLA)-DR expression 
on cultured normal human keratinocytes. Pretreat-
ment of keratinocytes with L-cycloserine or fumoni-
sin Bp but not I-phenyl-2-decanoylamino-3-mor-
pholino-l-propanol (PDMP), significantly suppressed 
both ICAM-l and HLA-DR expression induced by 
IFN-y. Because the synthesis of all kinds of sphingo-
lipids is blocl{ed by L-cycloserine and all except that 
of sphinganine by fumonisin B), whereas PDMP in-
hibits the synthesis of glucosylceramide and glyco-
sphingolipids, the result suggests the participation of 
cerami de and/or sphingosine in IFN-y-induced 
ICAM-l and HLA-DR expression. Exogenous C2-
cerami de reversed the effects of L-cycloserine and 
fumonisin B I' On the other hand, sphingosine re-
R ecent findings show that some biologic actions of cytokin es, such as tumor necrosis factor-a-induced apoptosis in human leukemic cell lines ]-IL- 60 and U937 (Obe id e/ aI, 1993; Jarvis e/ aI , 1994), inter-feron (I FN)-y-induced monocytic differentiation 
in HL-60 cells (Kjm c/ aI, 1991), lnterieukin (IL)-l/3-mediated 
production of prostaglandin E2 in human dermal fibroblasts (Ballou 
ct ai, 1992), IL-2 production in murine thymoma EL4 cell s (Mathias 
cl al 1993), and glioma cell process formation by nerve growth 
fa ctor (Dobrowsky c/ ai, 1994), are m ediated by sphingomyelin 
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versed the effect of L-cycloserine, but not of fumo-
nisin B). These results indicate that ceramide partic-
ipates in this pathway, as fumonisin Bi> but not 
L-cycloserine, inhibits the synthesis of ceramide from 
sphingosine. In addition, reverse transcriptase poly-
merase chain reaction showed that L-cycloserine re-
duced the mRNA for ICAM-l, HLA-DRa, and HLA-
DRf3 induced by IFN-y, and C2-ceramide and 
sphingosine antagonized the effect of L-cycloserine. 
Furthermore, the degradation rate of fluorescent 
sphingom.yelin into ceramide in keratinocytes was 
increased by IFN-y, suggesting that IFN-y activates 
sphingomyelin hydrolysis in keratinocytes. These ob-
servations suggest the possible role of ceramide in 
IFN-y-induced ICAM-l and HLA-DR expression on 
keratinocytes. Cerami de may function as all. endoge-
nous modulator mediating the cytokine signals in 
keratinocytes. Key I/lOl'ds: cytokille/splrlllgosille. ] IIIIJest 
DeYlllatoi 107:336-342, 1996 
turnover-initiated intracellular signal transduction, in w hi ch cer-
amide and/or sphingosine are the most probable candidates for 
second messengers. T hese cytokines also activate epiderma l kera-
tinocytes, as is manifested by the production of cytokin cs and 
expression of adhesion molecules (Nickoloff, 1991; Sauder, 1991). 
In add ition, epidermis conta ins large amoun ts of ceramide and 
sph ingosin e compared with other o rgans (Wertz and Downing, 
1991), but the role of ceramide and sphingosine in cytokine-
mediated signa l transduction in keratinocytes remains to be eluci-
dated. 
IFN-y indu ction of intercellular adh esion molecule (ICAM)-l 
and human le ukocyte antigen (HLA)-DR expression is one of the 
most well-known and vigorously studied cytokine actions on 
keratinocytes (Nickoloff, 1(91) . This phenomenon is thought to be 
a critical immunologic event in cutaneous illAammatory diseases 
(Walsh and Murphy, 1992; Katz, 1993), based on several facts. 
First, ICAM-1 and HLA-DR arc expressed on epidermal keratino-
cytes in many inAammatory skin diseases, but not in normal 
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epidermis (Griftiths e/ ai, 1989). Second, IFN-y-trea ted , maj o r 
histocompatibility complex class JI- and ICAM -I-positive kerati-
nocytes have th e abi lj ty to present bacterial superantigen to T ce lls 
(N ickoloff cI ai, 1993; Tokura el (/1, 1994) . T hird , the binding of 
bacterial superantigens to majo r histocomplHibility complex class II 
molecul es on keratinocytes upregulates IL-l a and tumor necrosis 
facto r-a production in keratinocytes (Tokura el ai, 1994). 
In this stud y, we examined the participation of ceramide and 
sphingosine in I FN-y-induced ICA M- 1 and HLA- DR expression 
on cultured n orma'! human keratinocytes by flow cytometry and 
reverse transcriptase polymel'ase chain reaction (IlT -PCR). O ur 
results demonstra te that ceramidc, bu t not sphingosine, plays a ro le 
in IFN-y-induced lCAM-l and H LA-DR expression on keratino-
cytes, suggestin g the importance of ceramide in the biologic action 
of cytokin es on keratinocytes. 
MATERJ ALS AND METHODS 
Chemicals L-cycloscrine. [umo nisin 13
" 
and rl'tl lls-d- erythro- 2-amino-4-
octadecene-I ,3-dio l (sphingosine) were purchased trom Sigma C hemical 
Co. (St. Louis. MO). 2- ceramide was prepared by N-acylation of 0-
e ryth rosphingosine using anhydrotic acetic ac id (molar ra tio J: 10), as 
described previousl)' (Wakita el ai, 1994). Purity of more than 95% was 
ve rified by hig h-performance liquid chro matography analysis (Wakita cr nl. 
1992). l-Phenyl-2-decanoylamino-3-morpholino- l -propanol (DL- threo-
PDMP) was from M,ltreya Inc. (Pleasant Gap, PAl. R.ecombinant human 
fFN- y was fro m Genzyme Corp. (Boston , M A). N-(l-Pyrenedecanoyl)-
sphingosylphosphocho line (py-C10-sphingomydill) was o btained from 
Molecular Probes, Inc . (Eugene, O R); py- C I O-ceramide was generated 
fro m the hydro lysis of py-C l a -sphingom ye lin by sphingomyel inase derived 
fro m Bacillus cereus (Sigma). Fluo resce in isothiocya natc (FITC)-conjugated 
monoclonal antibody 84 hl O (anti-human ICAM-l. m ouse IgGl) was 
obtained fro m Immunotcch (Marseille. France). FITC- conjugated m ouse 
IgG1 isotype contro l anti body, phycoerythrin-conjugated anti-HLA-DR 
monoclonal an ti body (L243), and phycoerythrin-conjugated mouse IgG2 
isorype control antibody were from Becto n D ickinson (Moun ta in View, 
CAl. All so lve n ts except acetic acid used in sphingom yelin hydro lysis 
ana lysis were nonAuo rescent (Dotite Lumioasol; Dojindo Laboratories, 
Kumamoto, Japan). Silica ge l 60 thin-layer chrom atography plates were 
fro m Merck (Darmstadt, German y). 
Cell Culture N o rmal human keratinocytes derived fi'om foreskins 
(Epipack; C lonetics Corp .. San D iego, CA) were grown in serum-free 
kera tinocyte growth medium (KGM; C lonetics) supplem ented with lO ng 
epidermal growth f.,ctor per ml and 60 ng w ho le bovin e pitui ta ry extract per 
ml in a humidified incubato r w ith 5'X. COo in air at 37°C. 
Induction of the lCAM-l and HLA-DR Molecules Cells at 90% 
conAuence were re-fed with KBM (KGM without ep idcrnwl growth f.,ctor 
Of w ho le bovine pituitary ""tract) conta ining 2 mM L-cydoserine, 25 J.LM 
fumo nisin B " o r 10 J.LM POMP for 96 h. Cell s we re then treated with 300 
U IFN-y per ml in fresh KBM with L-cycloserine . fi.1111 0nisin I3 , . o r POMP 
for an indicated period described later. In some e"periments, sphingosine or 
C2-ccramide in absolu te ethano l was added with the IFN-y. (The fi nal 
concentration of cach lipid and eth'lno l was 10 J.LM and 0.1 0/t., respectively.) 
Trypan blue dye e"c1us io n tests showed that the concentrations of the 
reagen ts described were not cyto toxic during cul tivatio n periods. All 
cu ltures were done in triplicate. 
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Figure 1. lFN- y indu ces ICAM-l and 
HLA-DR expression in c ultured norJ11al ke-
ratinocytes . Kcratinocytes were treated with 300 
U IFN-y per mI. with 10 J.LM of sphingos in e 
(Sph), o r with J 0 J.LM ofC2-ceramide (C2-cer) for 
48 h. Ke ratinocytes were labe led ,\"jth FITC-
coqjugatcd :1llti-hulllan ICAM-I 111 ol1oclonal an-
tibody (a) and phycoerythrin-conjugated anri-hu-
111an I-ILA-DR t110110c l o lla l antibody (b). as 
descri bed in JI /nrrlinls nlld JlI/elhotls. Cell s were 
analyzed by immu noAuorescence Aow cytometry. 
Data arc lucan ± SD of o ne representative tripli-
care cxpcrinlcl1t. Iden tica l results were obti)incd in 
three e"periments. ' Significan tly different from 
C2 ' C;Of lFNoy JFN.y IFN oy that of medium alone (p < 0.01). 
·Soh .C2 eel 
Flow Cytometry Sing le- ce ll suspensio ns were prepared by treatment of 
the cultured ce lls with 0.25% tryps in and I mM ethylenediamine tetrancetic 
acid in phosphate-buffered sa line (10 mM sodium phosphaw, 133 mM 
sodium chlo ride, pH 7.4). After washing with phosphate-buffered sa line. 
'105 cell s were incubated with 5 J.LI of FITC-conj ugated anti-I CAM-l 
mo noclolwl anti hody and phycoerythrin-conjugated an ti-H lA-DR mono-
clonal antibody, or with contro l antibodies from a mouse isoC)'pe. for 30 min 
o n icc. The stained ce ll s we re analyzed in a FACScan (Becton Dickinson). 
liv ing cell s were gated by propidium iodide staining. The data were 
ana lyzed using Consort 30 software (Becton Dickinson), and the lI1ean 
fluorescence intensity was calcu lated in log (orm . 
RT-PCR To compare the relative leve ls of induced gene products in 
mul tiple cell samples, reverse-transcribed samples were amplified for twO 
differen t cycles. and th e PCR band intensities were assigned SC11liq IJalltita-
tively by visua l inspection , as in a previo us report (Lagoo er nl, 1994). 
Tota l RN A was isolated by the single-step g uanid inium tlliocyanate 
method of C h0 111 czynski and Sacchi (1987) . After lysing of cell s in 
g uanid inium thiocyanate, we isolated RNA by phenol chloroform e"trac-
tion and ethano l precip itation. Tota l RNA (I J.Lg) was reverse transcribed to 
cDNA in the presence of2 .5 J.LM random he"amers . 1 mM deoxyllucleotide 
triphosphates. an d 2.5 U / J.LI reverse transcripta'l! (a ll from Perkin-Elmer 
Cctus. Norwa lk. CT), and then am plified for 28 or 39 cycles by using a 
GcncA mp RNA PC R kit (Perkin-Elmer Cetus) acco rding to the manuf.,c-
tUfer's instru ctions. Each cycle consisted of dcnatllr:1tioll at 94 °C for t I11in. 
annealing at 55a C fo r 1 min , and extension at 72 a C for 1.5 min. 
T he sequences of primer pairs,S' and 3', were as fo llows: ICAM- I . 
GTGACATGCAGCACCTCCTG and TCCATGGTGATCTCTCCTCA; 
HLA-DRa . GACAGGTTTTCCATTTCGAA and GATGAGATTTTC-
CATGTAGA; HLA- DR/3, CCCTGCAGCACCA AACCTCCT and CA-
GCCAGGCGGGAAAGCTTTT ; and /3-actin. GATTCCTATGTGGGC-
GACGA and GTGTCCATCACGATGCCAGT. Th" produc t size was 408 
bp for ICA M- 1. 299 bp fo r I-I LA-DRC/. 463 bp for HLA-DR.i3, and 3 1 ~ hp 
for /3-actin . Eight microliters of PC R products and DNA molecu lar weight 
m arker VI (Boehringer Mannheim GmbH Biochemica. Mannheim. Ger-
Ina ll ),) \vcre separated iJl 2fYo agarosc ge ls and visua lized with cthidiullJ 
bromide. 
Analysis of Sphingomyelin Hydrolysis Using the recently described 
method (Lcvade el til, 1995), we studied whether IFN-y actually activates 
sphingomyel in hydro lysis in keratinocytes. Before the e"periments were 
ini tiated, the ce ll s were incubated for 2 d in KBM; py-CIO-sphingomyel in 
in absolu te ethano l was then added to the cultured cell s. The final 
concentrations of Auorescent sphingomyelin and ethanol were 5 J.LM and 
0.1% (by volume), respective ly. After in -1.1b3tion at 3rC for 24 h. 300 U 
IFN-y per ml was added to the medium . Afte r incubation for the indicated 
rilnes, the cell s \verc \vas hcd three tinll!~ with phosph.Hc-bu(f"crcd s;,linc 
containing bovine serum albumin (2 m g per ml) and then twice with 
phosphate-buffered sa line . Cell s were harvested by scraping w ith rubher 
po licemen, and ce lls in suspens io n were sed imented by low-speed centrif-
ugation. suspended in 0 .25 ml disti lled water. and sonicated for 3 X 15 S. An 
aliquot was e"tracted wi til 1.25 III I of chloroform/methano l (2:1, by 
vo lume), vorte"-mi,,ed, and centrifuged at 1 000 X g for 15 min. The upper 
phase was discarded , and a thjn-Iayer chromatograph)' plate waS developed 
w ith the lipid il1 chloroform / methanol/acetic acid (94: I :5, by vol LIme) and 
illuminated under ul traviolet irradiation (366 11111; FUNA-UV light"). Fl uo-
rescence was detected onl), at the levels of py-C I O-sphingomye lin and 
ccranlidc. connrl11ing prev io us o bservations th ;lt ccra1l1idc is the sole 
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Figure 2. L-cycloserine, fumonisin B" and POMP selectively in-
hibit the activity of sphingolipid synthctic enzymes. Pathways fo.-
sphingolipid synthesis arc shown with the blocking site by L-cycloserine 
(L-CS), fu monisin ll" ,md PDM P. Sec text for deta iled explanation. 
product of the metaboli sm of Auorcscent sphingomyelin. T hc Auorescence 
in tcnsiL), of the li pid phase was then determined at the appropriate excitation 
and emission wavelengths (343 nm and 277 nm) in a spectroAuorometer. 
T he solvent was then evaporated under ni trogen, and the res idue was 
dissolved in 0.75 ml of heptanc, 0.225 ml of isopropyl alcohol, and 0.225 ml 
of water: after mixing and centri fuging, the upper phase was separated and 
back-washed with 0.1.75 ml of water. The Auorescence intensity of the 
upper, heptane-ri ch phase contain ing fluorescent ceramide (as checked by 
thin-layer chromatography) was measured. 
Statistical Analysis Data [rom tripLicate experiments were analyzed 
with the Stud en t's t test. Two oth e L" independent cXperiJ11ellts were 
performcd and gavc identica l results (statistica lly significant differences). 
RESULTS 
L-Cycloserine and Fumonisin B I Suppress IFN-y-Induced 
ICAM-1 and HLA-DR Expression on Keratinocytes Al-
though th e absolu te va lu es of log m ean fluorescence in tensi ty were 
dHferen t amon g experiments, sta ti stica lly signifi ca n t diffe ren ces, 
described late r, were in va riably observed in three ex perimen ts. 
Beca use ne ithe r IC AM-l no r HLA-OR. w as constitutively ex-
pressed o n non trea ted keratinocytes (Fig 1), w e fi rst stimula ted 
keratinocytes w ith sphin gosine and C2- ceramide at 1 to 30 J.LM for 
up to 72 h. Som e cells in m o re than 20 J.LM ceramide beca m e Aat, 
as in ce ll s of keratinocyte cell lin es (Wakita cI ai, 1994); however, 
n eith er ceramide nor sph.in gos in e could induce either ICAM-1 o r 
HLA-DR on keratinocytes (Fig 1). The results indicate tha t the 
increment of in trace ll u lar ceramide and sphin gos in e was n ot suffi-
cient for ICAM-J and HLA-OR. induc tion on ke ra tin ocytes. In 
Figure 3. L-cycloserinc and fumonisin H" but 
no t POMP, suppress IFN- y- induced ICAM-l 
and HLA-OR expression on keratinocytes . Ke-
ratinocytcs were prc inc ubatcd w ith o r w itho u t 2 
mM L-cycloscrine (L-CS) , 25 J.lM fUlllonisin ll" or 
1 0 J.lM PDMP fo r 96 h. Cells were then trea ted with 
300 U IFN-y per 111 1 with or without L-cyc1oserine, 
fumonisin B,. or PDMV for 48 h. Keratinocytcs 
were labeled with FITC-conjugatcd anti-human 
ICA M-l mon oclonal antibody (a) and phyco-
erythrin-conjugated anti-human HLA-DR mono-
clonal antibody (II) , as described in Ma lerials a"d 
Ml'lh oils . and analyzed by Aow cytometry. Data are 
mean ± SO of one rep rcsentative triplicate cxperi-
tTI cn t. Ide n tical resul ts we re o b tained in three ex-
periments. 'Significa ntly different from that of 
IFN-y alone (p < 0.01). 
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con trast, IC AM-1 and HLA-DR were induced by in cubation with 
300 U IFN-y per m l for 48 h (Fig 1) , and simul taneous addition of 
e ithe r sphingosine o r ceramide could n ot augm ent the e ffects of 
IFN- y (Fig 1). Altho u gh th e results suggest no participation of 
sphingosine o r ceramide in IFN-y-indu ced lCAM- '\ and HLA- DR 
expression, it is poss ibl e th at IFN-y at t his concentration mobilizes 
sa turating amo unts of endogeno us ceramid e o r sphin gos ine re-
q uired for ICAM-l and HLA-DR express ion . 
N ext, we sequ es tered endogenous sphin gos ine and ceramide 
be fore the additi on of IFN-y by using two k.inds of sphin golipid 
syn thes is inhibi to rs, in cluding L-cydoserine and fumon isin H" 
wh ich block the ac ti vities o f se rin e pa lmi toy ltra nsferase and sphin-
gos ine/sphin ga nine acyltransferase, respective ly (Sundaram and 
Lev , 1984; M errill CI ai, 1991) (Fig 2). T he synthesis of all kinds of 
sphingoLipids is inhibi ted by L-cydoserine and all except that of 
sphinganin e by fum o nisin B,. Because selective depletion of g ly-
cosphingo lipids alte rs cellular fu nctions (Barbour ci ai, 1992) , we 
also used the g lu cosylceram i.de synth etase inhibi to r PO MP, w hich 
blocks the synthesis of g lu cosylccra mide and glycosphingolipids. 
bu t not of sphingosin e and ceramide (Barbour c/ ai, 1992) (Fig 2) . 
Keratin ocytes w ere prein cubated w ith these agen ts for 96 h . 
Compared w ith contro ls, cells becam e sm all and ro und in the 
presence of L- cyd ose,'in e, w hereas cells were en larged by PDMP 
treatm ent, but L-cycloserin e , fumoni sin H" o r POMP did not 
induce ICAM-l or HLA- OR on ke ra tinocytes (da ta not shown) . 
Cells pre incubated w ith th ese agell ts for 96 h were then stimul ated 
wi th IFN- y for 48 h. Pretreatm ent of ke ratillocytes with L-
cycloserine and nllllonisin B" but not PDMP, significantly de-
creased the expression o fI C AM-l and HLA- DR. induced by IFN - y 
(Fig 3) . T he results suggest the requirem en t of sphin gos ine and / or 
ceramide, but not glu cosylce ramide, glycosphin goli pids, or sphin -
ganin e, in IFN-y-induced ICAM-1 and HLA- O R expression on 
ke ratin ocytes. 
C2-Ceramide But Not Sphingosine Inhibits the Suppressive 
Effects by F umonisul H , on IFN-y-Induced ICAM-1 and 
HLA-DR Expression W e n ext investigated whether the simul-
tan eous additio n of sphingos ine o r ceramide w ith IFN-y to L-
cyd oserine- O r fum o nisin B ,-pret,'eated ke ra ti nocytes modulates 
the expressio n o fi CA M - '\ and HLA-OR. T he suppress ive effects of 
L- cycloserin e on lCA M-l and HLA-OR express io n were largely, 
althou gh not completely, inhi bi ted by the concomitant in cuba tion 
of sphingosin e 0" C2-ceramide with IFN - y (Fig 4). In contrast, the 
suppressive effect of fUl11 0 nisin H , was inhibited by C2- ceramide, 
but n ot b y sphingosiJl e (Fig 5) . Because fum oni sin B " but not 
L-cydoserine, inhibits acy latio n of sphin gos ine to cerami de, the 
resul ts suggest tha t ceram ide, but no t sphingosine, participates in 
ICAM-l and I-lLA-DR inducti on by IFN-y. T he e ffect of sphin-
gosin e on L-cycloserine- treated kera tin ocytes mig h t be m ediated 
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F igure 4 . C2-ceramide and sphingosine antagonize the suppres-
sive effect of L-cycloserine 011 IFN- y-induced ICAM-t and 
lILA-DR expression on keratinocytes. Kcratinocytcs preincubatcd 
with or without 2 mM L-cycloscrin c (L-CS) for 96 h were treatcd with 300 
U IFN-y per ml with or w ithout 10 J.LM sp hingosine (Sp h) or 10 J.LM 
C2-ceramide (C2-cer) for 48 h. Keratinocytes were labeled with FITC -
conjugated anti-human ICAM- I monoclonal antibody (n) and phyco-
e rythrin-conjugated anti-human HlA-DR monoclona l antibody (b) , as 
described in Mala;ni" (/1111 Melhods . Cell s w e re ana lyzed by How cytolllctry. 
Data are mean ::!: SO of Olle representative tripli cate expcrimcnt. Identica l 
results \Verc obta ined in three experim ents. *Signifl cantiy difFerent froT11 
that of l-cycloscrinc- and IFN-'}'-trcatcd group (p < 0.01). 
by newly synthesized ce ram ide fj'om the acylation of exogen ous 
sphingosine. 
L-Cycloserine Decreases Levels of IFN-I'-Induced ICAM-l 
and HLA-DR mRNA in Keratinocytes, and C2-Ceramide 
Inhibits the Effect of L-Cycloserine To revea l th e site of 
action of ceramide in IFN-y-i.l1duced l CAM- l and HLA-DR 
expression on keratinocytes, w e extracted total RNA fj'om cultured 
kerati.nocytes and perform ed R T -PCR with primers specit'ic fo r 
ICAM- l, HLA-DRo:, HLA-DR{3, or {3-actin. 
As shown in Fig 6, lCAM -1 mRNA was not detected in cells no t 
exposed to IFN-y, whereas IFN-y induced ICAM-l nLRNA. 
Comparison of39-cycle PCR products showed that the signal fj-om 
keratinoc)'tes pretre;lted with L-cycloserine fo ll owed by IFN-y was 
weaker than that £i-om kerntinocytes treated with IFN-y without 
preceding L-cycloserin e treatment, and was at levels comparable to 
those in groups incubated with sphingos ine o r C2-cc ramide . In 
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Figure 5. C2-CCra_Jllidc~ but not spbingosine, antagonizes the sup-
pressive effect of fumonisin B, on IFN-'}'-induced ICAM-l and 
HLA-DR expression on keratinocytes. Kerati llocytcs prcillcub"tcd 
w ith o r witho lli' 25 J.LM flllllonisill 8, for 96 h were trcated with 300 U 
I FN-'Y per ml with or withom 10 JLM sphingos ine (Sph) or 10 J.LM 
C2-ccramide (C2-cer) for -l8 h . Kcratinocytcs were labeled with FITC-
co'~iugatcd ami-human ICA M-l m o noclollal an tihody (n) and phyco-
e rythrin-conjugated auri-h uman HLA-DR. m o noclonal anribody (Ii). as 
described in A,ln/erial ... · t1ud I\le/hods. CcUs were ana lyzed by Row cytO ll lCcr y. 
Data arc l1I e"n 2: SO of one represc n tative trip li ca t(' experimellt. Ide ntica l 
results were o btained in three cx pc ritl1cn ts. *Signitic;,ultly ciiffcrcnt fr0111 
that offumonisin I3,- and IFN-y-t.-cated g ro up (I' < 0.0 1) . 
contrast, 2tl-cycle PC R f'(li led to detect ICA M-1 mKNA in kenlti-
nocytes pretreated with L-cyclosel-i ll e, but ICAM-I I11I~A was 
present in ce lls incubated with sphingosine or C2-ceramide . This 
sem iquantitati ve PC R analysis indicates that L-cycloseri ne pretrea t-
ment suppresses the induction of ICAM-1 mRNA by " =N - y, and 
C2-ceramide and sphingosine dampen, at: least partially. the effects 
of L-cycloserine. 
HLA-DRo: was not detected in unsti mulated keratinocytes, and 
a strong HLA-DRo: signal was found by 39-cycle PC R ana lysis in 
keratinocytes treated with IFN-y for 12 h (Fig 7). T hese resu lts arc 
consistent with flow cytometric data showing no constitutive 
expression of H LA-D R molecules and showing induction of 
HLA-DR mol ecu les by IFN-y. This induction was not de tected in 
keratinocytes in cuba ted with IFN-y fo r 4 h (data not shown). 
consistenr with results described previously (Ker.- ('I (/1. 1990). We 
could not detec t diffe rences in sign al intensi ty between L-cy-
closcrine-pretreated and non pretreated I FN-")'-treated keratino-
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Figure 6. C2-eeralllide and sphingosine antagonize the suppres-
sive e ffect of L-cycloserine on IFN--y-induced ICAM-t mRNA. 
Kcratinocytes preincubated with or witho ut 2 111M L-cycloscrine (L-CS) for 
96 h were treated with 300 \J IFN-)' pcr 1111 w ith or without '10 Jl-M 
sphingosine (Sph) or 10 /LM C2-ccramidc (C2-Cer) for 4 h, To tal RNA was 
cxtnlctcd , and R T -PC R of ICAM-'I and /3-actin mRNA was perform ed as 
described in M aterials (/lid Methods, PCR products were ana lyzed by el ec-
trophoresis. Essenti all y identical results were ohtained in three experiments. 
cytes after 39-cycle PCR (Fig 7) . In contras t, 28-cycle PCR. 
showed obvio us differences between these samples. Whereas the 
I-!LA-DRa signal fro m L-cycloserine-pretrea ted sa mples was no 
longer visibl e, the signal fi'oll1 L-cycloserine-nonpretreated cells 
was modest but de tecta ble. In contrast, bands of both sph ingosin e-
and C2-ce ramide- trea ted sa mples were clearly visib le. 
T hirty-nine-cycl e PCR analysis showed a faintHLA-DR{3 p e R 
band in nonstimubted ketatinocytes and an intense band in kera-
tinocytes in cubated with IFN-y for 12 h (Fig 7) . Altho ugh there 
was no apparent difFe rence in signal intensity betw een L-cy-
c1oserine-treated and -nontreated keratinocytes after 39- cycle 
PCR. 28-cycle PCR showed that the HLA-DR.O' signal fi'ol11 
L-cycloserine-pretreated samples was weaker than that from L-
cycloserine-nonpretreated cells and sphingosine- and C2-cer-
amide-treated sa mples (Fig 7). 
{3-Actin was detected at compHabl e leve ls in all g ro ups by both 
28- and 39-cycl e PC R (Figs 7, 8). 
IFN-y Stimulates Degradation of Sphingomyelin into Cer-
amide in Keratinocytes By using the fluorescent sphingomye-
lin del;va tive. py-C I0-sphingomyeJin , w e investiga ted whether 
IFN-y cou ld stimu late degradation of sphingomyelin in keratino-
cytes. Initiall y, using thin-la yer chromatography, w e confl[llled that 
flu orescent ccramide is the sole product of the m etabolism of 
flu orescent sph.ingomyelin in both IFN-y-untrea ted and IFN-y-
treated ke ratiJlocytes (da ta not shown), in agreement with previou s 
observations (Levade et Ill , 1991a, 1991b, 1995). We thcn quanti-
fi ed sphingo m yeli.n h ydro lysis be fore and after J FN-y trea tment, as 
described previously (Levade ct Ill , 1995). As shown in Fig 8 , 
py-C 10-sphingomyelin hydrolysis was significantly upregulated i.n 
keratinocytes within 30 min after the addition of IFN-y, peaked at 
1 h, and then pla teau ed . The results indicate th at IFN-y activates 
sphingomyelin hydrolysis in keratin ocytes, but the effect of IFN-y 
was apparently w eaker than that of cxogenous sphingom ye linase 
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Figure 7. C2-ceraJl1ide and spitingosine antagonize the suppres_ 
sive effect of L-cycloserine on IFN-y-induced HLA-DRa and 
HLA-DR{3 mRNA in keratinocytes. Kc ratinocytes prcincubated with Or 
witho ut 2 mM L-cycloseriJle (L-CS) for 96 h were treated with 300 U 
1 FN-)' per Ill! with or without 10 /LM sphingosine (Sph) o r 10 /LM 
C2-ccranTi dc (C2-Ccr) for 12 h . Total R.NA was extl'actcd, ;lIld R T-PCR 
of H LA -DR.u , HLA-DR{3 , and {3-actin mRNA W:lS performed as described 
in Mnt" .. inls nlld Metl ,oris. PC n.. products were ana lyzed by ck ctrophoresis. 
bsscn tia ll y iden ti cal results were o btained in three cxpc.rirnents. 
(Jlig 8/). In addition , the le vels of fluorescent ceramide were not 
redu ced, at leas t within 4 h, sugges tin g that the fluorescent residues 
(pyrene) may prevent resynthesis o f sphingomyelin frol11 the fluo -
rescent cenll11ide. 
DISCUSSION 
Without the direct m e<lStlrem ent of endogenous sphingolipids, our 
resul ts demonstrate th ,]t ceramid e, but not sphingosine, participates 
in IFN-y-induced ICAM-1 and HLA-DR. expression on cultured 
human keratinocytes because of the followin g: (i) Inhibitors of the 
synthesis of ceramide, L-cycloserine and fumoni sin B
" 
significantly 
suppressed the efFect of IFN- -y; (ii) PDMP. wh.ic h blocks the 
synth esis of glycosphingolipids but not ceramide, fa iled to inhibit 
the effect of rFN-y; (iii) exogenous addition of ceramide restored 
the suppress ive effec ts of L-cycloserine and fumonisin B" whereas 
sphin gosine prevented suppression by L-cycloserine but not by 
fumonisin B,. w hich inhibits the conversion of sphingosine to 
ceramide (Rother ct Ill , 1992); and (iv) degradation of the fluores-
cein-labeled sphingomyelin in corporated by keratinocytes into 
ceramide was signifi cantly upregulated by IFN- y. This report 
demonstrates the participation of ce ramide in the biologic action of 
cytokines in keratinocytes . 
Ceramide might participate in IFN-y-induced ICAM-l expres-
sion on keratinocytes by at least two m echanisms. First, IFN-')' 
induces sphingomyelin turnover, as demonstrated in HL-60 ceUs 
(Kim el Il l , 1991), and liberated cerami de works as a second 
m essenger that activates ceramidc-activated protein kinases Ooseph 
ct Ill, 1993). leading to ICAM-l mRNA transC('iptioll . Second, 
Liberated cenllllide stabiLizes and protects JCAM-l mRNA from 
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degradation . Previo us studies sho wed that C2-ceramide al o ne 
mimics the elfects of cytokin es, such as inductioll o f apoptos is by 
tumor necrosis fac tor-a (O beid el aI, 1993; J arvis cl aI, 1994 ), 
monocytic differentiation o f H L-60 cells b), IFN- ')' (Kim el aI, 
1991) , and the e frect o f nerve growth fac tor o n ne uro nal cells 
(Dobrowsky el aI, 1994) , indica ting the direct participatio n o f 
c eramide as a second messenger. In this study, ho w ever, exogeno us 
C2-ceramide alo ne could no t dupli ca te the e ffe c t o f IFN-y on 
keratinocytes. In additio n, exogeno us sphingom yelina se, which 
hydrolyzed ceLl-associated flu orescen t sphingomyel in m o re e ffi -
ciently than IFN-y, could no t upregula te or induce ICAM - l and 
HLA-DR o n kera tinocytes (data not shown). T hus, the ti rs t 
mechanism is not plausible. Al tho ugh C D 28 signal transdu ction 
itself co uld not trigger biologic chan ges in lymph ocytes , co-
stimul ation of antigen receptors and C028 indu ces drasti c in creases 
in cell proliferati on and IL-2 produ ctio n (Lin sley el al, 1990) , in 
w hich C D 28 triggers sphingomye lin turn o ver and liberated cer-
amide stabilizes lL-2 mRN A (Gill cl aI , 1994) . T hu s, in keratino-
cytes, IFN-y triggers not o nly th e path wa ys of phospha tidyl.inosit-
id e turnover, whi ch direc tl y induce rC AM-1 e xpress io n (Griffiths el 
ai, 1990) , but also sphingom ye lin turnover , in which cer,llnide 
might stabilize mRNA fo r ICA M-I. 
In contrast to mRNA fo r ICA M-l, w hich was rapidl y induced in 
kerati.nocytes by IFN--y, the HLA-OR. gene was transcribed m ore 
slowly in keratinocytes by IFN--y. T his res ult is in agreem ent with 
previous repo rts (Kerr et aI, 1990; N ezu cl aI, 199 0) sugges ting that 
IFN-y induces the synth esis of poorl y de fin cd lralls-:lctin g hlc tors, 
w hich initiate HLA-OR genc transcrip tio n (Kerr et aI, 1990). T hu s, 
it is possible tha t cel':unide stabilizes mRNA fo r the trails-acting 
fac tors in additio n to mR.NA fo r H LA-OR. 
A lth o ugh fum o l1.i sin B, inhibits th e bi o logic ac ti on o f l FN-y 
w itho ut blocking the synthesis o f sphinganine , this fa ct does not 
ruJe out parti cipation o f fi'ee lo ng-chain bases in this bio logic 
actio n . R ather , it only 'indicates that sphinganine is no t <111 active 
participant in this pathway. Discrepancy in the bio logic actions of 
sp hin ganine and sphingosine is o fteJl enco uJl te red , such as in tlle 
induction o f tyrosine phospho rylation by sphin gosine but not by 
sphinganine, sugges ting th e impo rtan ce of the do ubl e bond in 
sphingosine fo r its bio logic ac ti vity (Seufferl ein and Rozengurt, 
1994). Sphingosin e, howe ver. cann ot anta gonize the suppressive 
effec t o f filJ11 0 nisin B I o n IFN-y-illduced IC AM-1 and H LA-O R 
exp ression . 
In addition to sphingosine and ceramide . mo re complicated 
sphingolipids such as glycosphingo lipids m ay regulate cellul ar 
fu n ctions, including cell to ce ll inte rac ti o n. cellular immunity, 
differenti ation , and cell adhes ion (Ha kom ori and Igara shi , 1993 ). 
For example , depletion of glycosphingolipids inhibi ts growth and 
cell- substrate adhesion of human A43 1 epidermoid carc in oma cell s 
(Ba rbo ur el aI, 1992) . T hus, we also used POMP to in vestigate 
w h e ther redu ction of glycosphingo lipid synthesis m odu lates 
rCAM-l and HLA-OR. expression on keratin ocytes . O ur resul ts, 
IFN Y Sph lO90myetrnasc 
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Figure 8. IFN-y upregulates sphingomyelin 
hydrolysis in keratinocytcs. C ul tu red ke ratino-
cytes w ere incuba ted w ith 5 jLM py-C l a - sphingom y-
din fo r 24 h . Cell s were then incuba ted w ith 30n U 
IFN-y pe r m l (o r the ind icated [ime (a). In b) . ce ll s 
were incuba ted w ith 30n U IFN-y pe r 1111 o r 0 . .1 m U 
sphin go rnyc linase pe r 1111 for 2 h. T he anlo u nts 
(mean :!: SD) o f the fluorescent ceramide (orm ed 
were de termined as described in Materials alld Mcth"ds 
and an : expressed as pe rcentage of tb e total ce ll -
associated flu o rescence . Essentia ll y iden ti ca l resul ts 
wcrc o b ta ined in three cxpe rim en ts. ' Sig ni fi cantl y 
d i!fc n :n t trom that or com ro l (p :5 0.05). 
ho wever, sugges t that glycosphingolipid does not ac tively partici-
pate in IFN-y-il1duced lCAM-1 and H LA- O R expression . As for 
POMP, it sho uld be noted that som e o f tlle bio logic e ffects of 
POMP, especially that of the L- threo isom er of PO MP, m ay be 
independen t of the inhibitio n of glu cosylceramide syn thetase (R a-
din ei aI, 1993) . Fo r example, L-PD MP is pos tulated to exert a 
direct stimul atory effect o n th e galactosyltran sfe rase (C hatterjee. 
199 1), bu t OL-POMP. used in this study, did no t reduce IFN--y-
indu ced IC AM-1 and H LA- OR express io n. 
R ecently, Bose cl al (1 995) demonstrated 3n altern ative mecha-
nism fo r ceramide genera ti on. T hey showed that ceramide is 
generated by ceramide syn thase, bur no t by sphingom yel in hydro-
lys is, during 3nthracyclin e-induced apo ptosis. Although o ur study 
shows the hydro lys is of sphingomye lin by IFN- y, the effect wa s 
weaker than th at observed in H L- 60 cells (Kim et aI, 1991 ). In 
addi tion, o ur data sugges t tha t cermnide is no t directly in volved as 
a second m essenger, bu t rather as an ancillary e ffec to r in tlle IFN- y 
pathwa y. T hus. it is possibl e that cerami de-generating p athways 
other tban sphingomyelin hydro lys is arc presen t in keratin oc), tcs. 
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